Filed: 2/17/2026ACC: 0001172661-26-001155
📋 What this filing means
ANTARA CAPITAL LP filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $30.2K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$30.2K
Total AUM (reported)
410.59K
Total Shares
Allocation by class
COM$26.8K88.6%
*W EXP 02/14/203$3.4K11.4%
Portfolio Concentration
Top 3$30.2K100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 410.59K
Sole
Full voting authority
410.59K
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
ASPIRE BIOPHARMA HLDGS INC
SOLEShares202.90K
TypeSH
Market value$26.8K
88.65%
Sole
202.90K
Shared
0.00
None
0.00
ASPIRE BIOPHARMA HLDGS INC
SOLEShares207.69K
TypeSH
Market value$3.4K
11.35%
Sole
207.69K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ASPIRE BIOPHARMA HLDGS INCSOLE | COM | 202.90K | SH | $26.8K 88.65% | 202.90K | 0.00 | 0.00 |
ASPIRE BIOPHARMA HLDGS INCSOLE | *W EXP 02/14/203 | 207.69K | SH | $3.4K 11.35% | 207.69K | 0.00 | 0.00 |